GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NKGen Biotech Inc (NAS:NKGN) » Definitions » Price-to-Free-Cash-Flow

NKGen Biotech (NKGen Biotech) Price-to-Free-Cash-Flow : N/A (As of May. 26, 2024)


View and export this data going back to 2023. Start your Free Trial

What is NKGen Biotech Price-to-Free-Cash-Flow?

As of today (2024-05-26), NKGen Biotech's share price is $1.42. NKGen Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.51. Hence, NKGen Biotech's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for NKGen Biotech's Price-to-Free-Cash-Flow or its related term are showing as below:

NKGN's Price-to-Free-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 31.69
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

NKGen Biotech's Free Cash Flow per Share for the three months ended in Mar. 2024 was $-0.18. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $-0.51.


NKGen Biotech Price-to-Free-Cash-Flow Historical Data

The historical data trend for NKGen Biotech's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NKGen Biotech Price-to-Free-Cash-Flow Chart

NKGen Biotech Annual Data
Trend Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
- - -

NKGen Biotech Quarterly Data
Dec21 Sep22 Dec22 Mar23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial - - - - -

Competitive Comparison of NKGen Biotech's Price-to-Free-Cash-Flow

For the Biotechnology subindustry, NKGen Biotech's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NKGen Biotech's Price-to-Free-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NKGen Biotech's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NKGen Biotech's Price-to-Free-Cash-Flow falls into.



NKGen Biotech Price-to-Free-Cash-Flow Calculation

NKGen Biotech's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=1.42/-0.505
=N/A

NKGen Biotech's Share Price of today is $1.42.
NKGen Biotech's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.51.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

NKGen Biotech  (NAS:NKGN) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


NKGen Biotech Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of NKGen Biotech's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


NKGen Biotech (NKGen Biotech) Business Description

Traded in Other Exchanges
N/A
Address
19700 Fairchild Road, Suite No. 300, Irvine, CA, USA, 92612
NKGen Biotech Inc is a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies utilizing our proprietary SNK (super-activated) platform.